(Q43660405)

25 November 2017

title

Effect of a long-acting beta2-agonist over three months on airway wall vascular remodeling in asthma (English)

1 reference

microvasculature remodeling

25 November 2017

0 references

1 reference

7

1 reference

25 November 2017

Orsida BE

1

1 reference

25 November 2017

Ward C

2

1 reference

25 November 2017

Li X

3

1 reference

25 November 2017

Bish R

4

1 reference

25 November 2017

Wilson JW

5

1 reference

25 November 2017

Thien F

6

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

American Journal of Respiratory and Critical Care Medicine

25 November 2017

published in

1 reference

25 November 2017

volume

164

1 reference

25 November 2017

issue

1

1 reference

25 November 2017

page(s)

117-121

1 reference

Asthma control during long-term treatment with regular inhaled salbutamol and salmeterol.

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.1.2006003

Vascularity in asthmatic airways: relation to inhaled steroid dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.1.2006003

Regular inhaled beta-agonist treatment in bronchial asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.1.2006003

The use of beta-agonists and the risk of death and near death from asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.1.2006003

Potential masking effects of salmeterol on airway inflammation in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.1.2006003

Effect of high dose inhaled fluticasone propionate on airway inflammation in asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.1.2006003

Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.1.2006003

Inhaled corticosteroid reduced lamina reticularis of the basement membrane by modulation of insulin-like growth factor (IGF)-I expression in bronchial asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.1.2006003

Vascularity in asthmatic airways: relation to inhaled steroid dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.1.2006003

Measurement of airway responsiveness to methacholine: relative importance of the precision of drug delivery and the method of assessing response

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.1.2006003

Interleukin-8 as a macrophage-derived mediator of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.1.2006003

Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.1.2006003

Ligand-independent activation of the glucocorticoid receptor by beta2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.1.2006003

10.1164/AJRCCM.164.1.2006003

21 January 2018

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3aoyh33kt5adpcxexlpz6o5xnq

mapped directly with Wikidata item

30 July 2022

based on heuristic

Fatcat ID

release_3aoyh33kt5adpcxexlpz6o5xnq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3aoyh33kt5adpcxexlpz6o5xnq

mapped directly with Wikidata item

30 July 2022

based on heuristic

https://api.fatcat.wiki/v0/release/3aoyh33kt5adpcxexlpz6o5xnq

1 reference